Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Category: Science blog February 1, 2017
Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer.
We take a look at some of our new, pioneering clinical trials.
There’s more to stopping cancer from spreading than simply cutting out chocolate, despite what the headlines say.
Category: Science blog October 11, 2016
On Ada Lovelace Day 2016, we speak to Dr Bissan Al-Lazikani about how she is using computers to help personalise cancer treatment.
We explore how clinical trials are run, and hear from a patient about what it’s like taking part in a cancer clinical trial.
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.
Category: Science blog July 21, 2016
Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.